Non-tricyclic and Non-selective Serotonin Reuptake Inhibitor Antidepressants and Recurrent Falls in Frail Older Women

American Journal of Geriatric Psychiatry

Volumn 24, Issue 12, 2016, Pages 1221-1227

  Naples, Jennifer G ^a,b   Kotlarczyk, Mary P ^a   Perera, Subashan ^a,c   Greenspan, Susan L ^a   Hanlon, Joseph T ^a,b,d  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

antidepressants; frailty; long term care; older adults; recurrent falls

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; CITALOPRAM; ESCITALOPRAM; FLUOXETINE; IMIPRAMINE; MIRTAZAPINE; NORTRIPTYLINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; ZOLEDRONIC ACID; ANTIDEPRESSANT AGENT; MIANSERIN;

AGED; ARTICLE; COGNITIVE FUNCTION TEST; COHORT ANALYSIS; COMORBIDITY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EXPOSURE; ESTIMATED GLOMERULAR FILTRATION RATE; FALLING; FEMALE; FRAIL ELDERLY; HUMAN; LONG TERM CARE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; OSTEOPOROSIS; OUTCOME ASSESSMENT; PREVALENCE; RANDOMIZED CONTROLLED TRIAL; SECONDARY ANALYSIS; VERY ELDERLY; ANALOGS AND DERIVATIVES; RECURRENT DISEASE; RISK FACTOR; STATISTICS AND NUMERICAL DATA;

ACCIDENTAL FALLS; AGED, 80 AND OVER; ANTIDEPRESSIVE AGENTS; BUPROPION; FEMALE; FRAIL ELDERLY; HUMANS; MIANSERIN; RECURRENCE; RISK FACTORS; SEROTONIN UPTAKE INHIBITORS; TRAZODONE;

EID: 84999026136     PISSN: 10647481     EISSN: 15457214     Source Type: Journal    
DOI: 10.1016/j.jagp.2016.08.008     Document Type: Article

References (36)

1. 1 Harris-Kojetin, L., Sengupta, M., Park-Lee, E., et al. Long-term care services in the United States: 2013 overview. Vital Health Stat 3 (2013), 1–107.
2. 2 Thakur, M., Blazer, D.G., Depression in long-term care. J Am Med Dir Assoc 9 (2008), 82–87.
3. 3 Seitz, D., Purandare, N., Conn, D., Prevalence of psychiatric disorders among older adults in long-term care homes: a systematic review. Int Psychogeriatr 22 (2010), 1025–1039.
4. 4 Gaboda, D., Lucas, J., Siegel, M., et al. No longer undertreated? Depression diagnosis and antidepressant therapy in elderly long-stay nursing home residents, 1999 to 2007. J Am Geriatr Soc 59 (2011), 673–680.
5. 5 Hanlon, J.T., Wang, X., Castle, N.G., et al. Potential underuse, overuse and inappropriate use of antidepressants in older veteran nursing home patients. J Am Geriatr Soc 59 (2011), 1412–1420.
6. 6 Boyce, R., Hanlon, J.T., Karp, J.F., et al. A review of the effectiveness of antidepressant medications for depressed nursing home residents. J Am Med Dir Assoc 13 (2012), 3216–3231.
7. 7 Woolcott, J.C., Richardson, K.J., Wiens, M.O., et al. Meta-analysis of the impact of 9 medication classes on falls in elderly persons. Arch Intern Med 169 (2009), 1952–1960.
8. 8 Thapa, P.B., Gideon, P., Fought, R.L., et al. Psychotropic drugs and risk of recurrent falls in ambulatory nursing home residents. Am J Epidemiol 142 (1995), 202–2011.
9. 9 Thapa, P.B., Gideon, P., Cost, T.W., et al. Antidepressants and the risk of falls among nursing home residents. N Engl J Med 339 (1998), 875–882.
10. 10 Deandrea, S., Bravi, F., Turati, F., et al. Risk factors for falls in older people in nursing homes and hospitals. A systematic review and meta-analysis. Arch Gerontol Geriatr 56 (2013), 407–415.
11. 11 Gebara, M.A., Lipsey, K.L., Karp, J.F., et al. Cause or effect? Selective serotonin reuptake inhibitors and falls in older adults: a systematic review. Am J Geriatr Psychiatry 23 (2015), 1016–1028.
12. 12 Wong, J., Motulsky, A., Eguale, T., et al. Treatment indications for antidepressants prescribed in primary care in Quebec, Canada, 2006–2015. JAMA 315 (2016), 2230–2232.
13. 13 Kallin, K., Gustafson, Y., Sandman, P.-O., et al. Drugs and falls in older people in geriatric care settings. Aging Clin Exp Res 16 (2004), 270–276.
14. 14 Gribbin, J., Hubbard, R., Gladman, J., et al. Serotonin-norepinephrine reuptake inhibitor antidepressants and the risk of falls in older people: case-control and case-series analysis of a large UK primary care database. Drugs Aging 28 (2011), 895–902.
15. 15 Marcum, Z.A., Perera, S., Thorpe, J.M., et al. Antidepressant use and recurrent falls in community-dwelling older adults: findings from the Health ABC study. Ann Pharmacother 50 (2016), 525–533.
16. 16 Greenspan, S.L., Perera, S., Ferchak, M.A., et al. Efficacy and safety of single-dose zoledronic acid for osteoporosis in frail elderly women: a randomized clinical trial. JAMA Intern Med 175 (2015), 913–921.
17. 17 Pahor, M., Chrischilles, E.A., Guralnik, J.M., et al. Drug data coding and analysis in epidemiologic studies. Eur J Epidemiol 10 (1994), 405–411.
18. 18 Ensrud, K.E., Blackwell, T.L., Mangione, C.M., et al. Central nervous system-active medications and risk for falls in older women. J Am Geriatr Soc 50 (2002), 1629–1637.
19. 19 Huang, A.R., Mallet, L., Rochefort, C.M., et al. Medication-related falls in the elderly: causative factors and preventive strategies. Drugs Aging 295 (2012), 359–376.
20. 20 American Geriatrics Society 2015 Beers Criteria Update Expert Panel, American Geriatrics Society 2015 Updated Beers Criteria for potentially in appropriate medication use in older adults. J Am Geriatr Soc 63 (2015), 2227–2246.
21. 21 Coupland, C.A., Dhiman, P., Barton, G., et al. A study of the safety and harms of antidepressant drugs for older people: a cohort study using a large primary care database. Health Technol Assess 15 (2011), 1–202.
22. 22 Gagne, J.J., Patrick, A.R., Mogun, H., et al. Comparative safety of antidepressants on fracture risk in older adults. Clin Pharmacol Ther 89 (2011), 880–887.
23. 23 Bakken, M.S., Engeland, A., Engesæter, L.B., et al. Increased risk of hip fracture among older people using antidepressant drugs: data from the Norwegian Prescription Database and the Norwegian Hip Fracture Registry. Age Ageing 42 (2013), 514–520.
24. 24 Stahl, S.M., Lee-Zimmerman, C., Cartwright, S., et al. Serotonergic drugs for depression and beyond. Curr Drug Targets 14 (2013), 578–585.
25. 25 Sheehan, D.V., Croft, H.A., Gossen, E.R., et al. Extended-release trazodone in major depressive disorder: a randomized, double-blind, placebo-controlled study. Psychiatry 6 (2009), 20–33.
26. 26 Carpenter, L.L., Yasmin, S., Price, L.H., A double-blind, placebo-controlled study of antidepressant augmentation with mirtazapine. Biol Psychiatry 51 (2002), 183–188.
27. 27 Pfeiffer, E., A short portable mental status questionnaire for the assessment of organic brain deficit in elderly patients. J Am Geriatr Soc 23 (1975), 433–441.
28. 28 Rigler, S.K., Studenski, S., Wallace, D., et al. Comorbidity adjustment for functional outcomes in community-dwelling older adults. Clin Rehabil 16 (2002), 420–428.
29. 29 Kroenke, K., Spitzer, R.L., Williams, J.B., The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 16 (2001), 606–613.
30. 30 Hanlon, J.T., Boudreau, R.M., Roumani, Y.F., et al. Number and dosage of central nervous system medications on recurrent falls in community elders: the Health, Aging and Body Composition study. J Gerontol A Biol Med Sci 64A (2009), 492–498.
31. 31 Semla, T.P., Beizer, J.L., Higbee, M.D., (eds.) Geriatric Dosage Handbook, 21st ed., 2015, Lexicomp, Hudson, OH.
32. 32 Diggle, P.J., Heagerty, P., Liang, K., et al. (eds.) Analysis of Longitudinal Data, 2nd ed., 2002, Oxford University Press, New York, NY.
33. 33 Sweet, R.A., Pollock, B.G., Kirshner, M., et al. Pharmacokinetics of single- and multiple-dose bupropion in elderly patients with depression. J Clin Pharmacol 35 (1995), 876–884.
34. 34 Koka, R.M., Nolenb, W.A., Heerenc, T.J., Efficacy of treatment in older depressed patients: a systematic review and meta-analysis of double-blind randomized controlled trials with antidepressants. J Affect Disord 141 (2012), 103–115.
35. 35 Roose, S.P., Dalack, G.W., Glassman, A.H., et al. Cardiovascular effects of bupropion in depressed patients with heart disease. Am J Psychiatry 148 (1991), 512–516.
36. 36 Spina, E., Trifirò, G., Caraci, F., Clinically significant drug interactions with newer antidepressants. CNS Drugs 26 (2012), 39–67.